We have studied, by the immunohistochemical method, the leukocyte infiltration and the expression of adhesion molecules ICAM-1 and VCAM-1, both glomerular and interstitial, in the renal biopsies (RB) of 15 patients with the clinical and morphological diagnosis of primary renal vasculitis (7 WG, 5 MPA, 3 "idiopathic necrotizing GN").
Ravazzolo, and R. Gusmano, Department of Nephrology, G. Gaslini Institute of Genoa (I), Genoa and I.Bi. G. University of Genova (I), Italy. TGFf3 is a potential determinant of tubulointerstitial fibrosis; however, a clear demonstration of a fibrogenic effect of TGF!3 with renal cells is still lacking. We evaluated whether TGFI3 (0-5 ng/ml) modulates the expression of collagens by tubular epithelial cells (NRK52E) and interstitial fibroblasts (NRK49F and Cvi). Collagens were extracted from 3H proline labeled cells after partial pepsin digestion and were analyzed by SDS-PAGE and autoradiography. Observed was a cell specific effect of TGFII which up-modulated the expression of [a (111)3] by NRK52E (+200%), while inhibiting interstitial fibroblasts. Parallel experiments performed on homologous cells transfected with the promoter of al (III) collagen gene linked to luciferase demonstrated a comparable effect of TGFI3 on al (III) collagen transcription in NRK52E. These observations indicate a stimulatory effect of TGF on both transcription and expression of al (III) collagen by tubular epithelial cells. This mechanism is potentially implicated in ECM regulation during tubulointerstitial fibrosis.
Erythrocyte Ca transport in idiopathic hypercalciuria: Relation to Ca intestinal absorption and bone mineral density. G. Vezzoli, MC. Reina, L. Soldati, G.L. Moro, A. Rubinacc4 P. Rigatti, and G. Bianchi, Division of Nephrology and Dialysis, S. Raffaele Hospital, Milan, Italy. The relationship between cell membrane Ca transport and Ca metabolism was evaluated in idiopathic hypercalciuria (IH). We studied Ca-ATPase activity and passive Ca influx in erythrocytes obtained from 56 patients with nephrolithiasis: 29 of them had IH (calcium excretion> 100 tmol/kg bodywt), and the other 37 patients were normocalciuric. Ca-ATPase was measured in washed erythrocyte membranes at Vm using a coupled enzyme assay. Ca influx was evaluated measuring strontium influx in washed erythrocytes, incubated with Sr (3 mM) in the presence of vanadate (Ca-ATPase inhibitor). Moreover, intestinal absorption of Ca was studied using an oral load of stable Sr (2.65 mg/kg body wt) and expressed as the fractional absorption of the administered oral dose after 1 hour; bone mineral density of lumbar vertebrae (BMD L1-L4) and femur (BMD F) was assessed by dual x-ray absorptiometry. Ca absorption (20% 1.3 vs. 14% 1; P < 0.005) and Ca-ATPase activity (50 2.4 vs. 41 2.7 nmol ATP split/mm/mg; P < 0.02) were increased in patients with IH. Sr influx was not different in the 2 groups (55 4.9 vs. 52 5.0 smol/liter erythrocytes after 40 mm).
Ca-ATPase activity was positively correlated with calciuria (r = 0.24; P < 0.05), but not with the values of Ca intestinal absorption. When hypercalciuric patients were considered, Ca-ATPase was positively correlated with BMD L1-L4 (r = 0.42; P < 0.05) and BMD F (r = 0.46; P < 0.05). Sr influx was not correlated with Ca metabolism parameters. Patients with IH were divided in 2 subgroups according to their mean value of Ca-ATPase activity: the first with activity < 50 (N = 16) and the other > 50. The value of BMD F was significantly lower in the first subgroup (857 23 g/cm2 vs. 965 36; P < 0.025), whereas BMD L1-L4 was slightly lower (931 34 vs. 1018 34). The other parameters were not different. These results suggest that membrane Ca-ATPase activity is increased in IH, especially in the patients with normal bone mineral density. Bone and tubular cells have a Ca-ATPase similar to that found in erythrocytes. It is possible that the increase of Ca-ATPase activity prevents BMD reduction by limiting urine Ca wastage or influencing bone cell function.
A new genic mutation in a family affected by X-linked nephrogenic diabetes insipidus (ND!) and intracranial calcifications (IC). R. Bellantuono, M. Giordano, S. Simonetti, F. Papadia, F. Carnevale, D. G. Bichet, and D.A. Caringella, Nephrology and Dialysis Division, Metabolic Diseases and Medical Genetic Division, Pediatric Hospital "Giovanni XXIII," Ban, Italy, and University of Montréal, Montréal, Quebec, Canada. Hereditary NDI is a rare disease in which the renal collecting tubule cells fail to respond to antidiuretic hormone (arginine vasopressin) due to the presence of a mutation in the gene for the V2 receptor. This gene is located in chromosome region Xq28. We recently studied a family from a Southern Italian region, Puglia, in which two male cousins (10 and 9 years of age) were affected by NDI. Computed tomography revealed bilateral and multicentric IC. A detailed study of the family pedigree showed a third affected member with neurological damage. He was a mother's uncle of the probandi. Moreover, four other brothers of the last member mentioned died in their first year of age due to unknown causes. Segregation analysis of the three affected members by polymerase chain reaction (PCR) showed the presence of a mutation in the reading frame of the V2 receptor gene. The disease is segregating with the 2900 base pair (bp) alleles also present in the mothers of the probandi (obligate carriers), in their mother (grandmother of the probandi), and in a proband's sister. This study allowed the identification of a new mutation associated with NDI. There are 16 more mutations described in the literature associated with the disease. Up to now, 7 cases of NDI and IC were described. None of them was studied by molecular analysis. It is to be determined whether IC are a phenotypical consequence of the same mutation, or the effect of hypernatremia during the first months of life.
IgA nephropathy: Expression of smooth muscle a-actin in mesangial cells. C. Oliva, G. Pecci, GA. Cinotti, and P. Barsotti, Departments of Experimental Medicine and Nephrology, "La Sapienza" University, Rome, Italy. Expression of smooth muscle a-actin (aSMA) has been demonstrated in proliferating mesangial cells and has been proposed as a marker of mesangial cell activation. Mesangial cells expressing the aSMA phenotype might contribute to modulating glomerular lesions and renal injury progression in IgA nephropathy (IgAN). To verify this hypothesis, we evaluated oSMA expression, using an anti-oSMA mab (Dako), in 30 renal biopsies from 30 patients with IgAN (25 M, 5 F; aged: 10-54 years). a-SMA data (evaluated by means of a semiquantitative arbitrary scale) were compared with the level of glomerular proliferation (evaluated as number of anti-PCNA mab positive nuclei/glomerular section), graded histological lesions and clinical aspects. In our patients with IgAN, up-regulation of mesangial sSMA expression (with a mean score of 2.1 0.2 SEM) was observed. aSMA score was higher (P < 0.01) in the biopsies with grade V lesions. It showed a positive correlation with the grade of extracapillary lesions (P < 0.05), with the presence of endocapillary exudation (P < 0.05), and with the glomerular proliferation index (mean value of 1.6 0.4 SEM, P > 0.05). Thus, it is possible to suggest that in IgAN, mesangial synthesis of aSMA may be an early step in the glomerular response to mediators of inflammation. It is also worth noting that in patients who experienced a recent (1 year) episode of macroscopic hematuria at time of the biopsy the aSMA score showed a negative correlation (NS) with the time lapse between the macro-hematuria and the renal biopsy. The possible role of the mesangial aSMA phenotype in effecting the renal damage progression in IgAN remains an attractive hypothesis. Of interest is the observation of a lower aSMA expression (1.87 0.2 to 2.53 0.4, NS) in biopsies from patients with macroscopic hematuria (a subgroup of patients who has been reported to have a better prognosis) and of a higher level of aSMA (3.18 0.3 to 1.87 0.2, P < 0.01) in the 2 patients with normal GFR at the biopsy time and renal function impairment at the follow-up. we have studied Ca enteral absorption in 10 patients with Gitelman syndrome, in their healthy brothers (N = 8), in their parents (N = 13), and in 10 healthy controls. Ca enteral absorption was evaluated according to the method of Reid et al using an oral load of stable strontium (2.65 mg/kg body wt) and expressed as the fractional absorption (FA Sr) of the administered oral dose after 1 and 4 hours. Patients had magnesemia < 0.7 mat, kalemia < 3.5 mat, and bicarbonatemia > 28; their 24 hour Ca excretion was < 0.08 mM/mM creatinine. Sr absorption was significantly increased in patients 4 hours after Sr oral administration (P < 0.05 vs. other groups; ANOVA and Fisher test), whereas it was only slightly increased after 1 hour. Moreover, 24 hour Ca excretion was significantly decreased with reduced Ca fractional excretion (P < 0.05), whereas Cl and K fractional excretions were significantly increased in patients (P < 0.05). DQB1 and DQA1 alleles showed frequencies in patients and controls in accordance with the well-known linkage disequilibria (LD) with DRB1 alleles: DQA1*0101 and DQB1*0501 alleles (in LD with DRB1*0101) were increased in patients while DQA1*02 and DQB1*0201 (in LD with DRB1*07) were reduced. No differences were found comparing HS patients with or without findings of kidney disease. Subdividing patients with renal disease according to the presence of DRB1*01 or DRB1*11 alleles, the mean age at biopsy was earlier in positive patients (22.6 18 years) than in negative patients (30.9 21; P = 0.002), and the mean number of relapse episodes per patient was higher in the first group (3.6 2 vs. 1.7 9; P = 0.04). Frequencies of RFLPs at IgA switch regions were similar in patients and controls. These results support the hypothesis that genetic factors may contribute to HS susceptibility. In particular, the presence of arginine at position 71 of DRB1 chain (shared by DR1 and DR1 1 alleles) seems to confer a higher risk of disease, while the presence of isoleucine at position 67 of DRB1 chain (coded by both DR15 and DR7 genes) seems to confer protection. We may hypothesize that these aminoacidic residues of DRB1 molecules are relevant in presentation to T cells of some peptides against which the immune system reacts, leading to HS manifestations.
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ANCA isotype in ANCA positive vasculitis with pulmonary hemorrhage. G. Gregorini, A. Sinico, P. Tira, G.P. Bosi, S. Tunes4 G. Palmerio, and R.
Majorca, Department of Nephrology and Pulmonary Function Laboratory
Spedali Civili and University of Brescia, Department of Nephrology, S. Carlo Hospital, Milan, Italy. 1gM ANCA have been found in conjunction with IgG ANCA in the subgroup of patients who develop pulmonary hemorrhage (PH) due to diffuse alveolar capillaritis. Due to the intravascular distribution and longer persistence in the blood of this class of antibodies, 1gM ANCA have been suggested to sustain a pathogenic role in PH.
Consequently, 1gM ANCA tests were recommended in all ANCA positive patients and treatment with plasma exchange systems that efficiently remove 1gM was suggested in positive patients. We retrospectively looked for 1gM ANCA in the first serum of 70 patients with IgG ANCA positive vasculitis, 24 patients with C-ANCA and 46 with P-ANCA. 1gM ANCA were detected by both indirect IF and by ELISA using as antigens purified MPO and alpha granules, and 24/70 patients had pulmonary hemorrhage. PH was diagnosed on the basis of presence of hemoptysis, radiological interstitial-alveolar opacification, and raised coefficient of diffusing capacity of CO (more than 30% of predicted normal). 1gM ANCA turned out positive in 26/70 patients. 1gM ANCA specificity was the same as IgG ANCA. 1gM ANCA were found in 15/24 (58%) patients with PH and in 11/46 (24%) patients without PH confirming a prevalence of 1gM ANCA in the group of patients with PH (P < 0.001). Patients with 1gM ANCA and no PH did not develop PH after a long follow-up. PH in 15 patients with 1gM ANCA was not more severe than in 9 patients who were 1gM ANCA negative; however, PH relapsed in only two patients who were 1gM ANCA positive. Presence of 1gM ANCA did not correlate with the presence of rheumatoid factor. Serum levels of total 1gM were significantly higher in 1gM ANCA positive patients than in 1gM ANCA negative patients (148 36 mg/dl vs. 106 68 mg/dIP < 0.002). Our data confirm the association between 1gM ANCA and PH. However, severe PH can develop in patients who were 1gM ANCA negative and patients could have for long time high titers of 1gM ANCA without any evidence of PH. Total levels of 1gM seem to be related to the presence of 1gM ANCA. of dialysis biocompatibility, as circulating molecules and lympho-monocyte products, does not examine directely the endothelial (E) reactivity, triggered by mediator release. NO is a powerful vasoactive product of E origin and its major effect is a vasodilation leading to hypotension. We present an original assay to test the effects of the interaction between blood-dialysis membrane and the F layer. To this aim the NO production by E cells in culture (EC) was measured after the mediator release induced by dialysis (HE). Three in vitro HE sessions were performed using cuprophane (Cu) and polymethylmethacrylate (PMMA) membranes. Recirculating donor blood samples at 0, 5, 15, 30 and 60 minutes were coincubated with murine EC for 6 hours. Then, mRNA for inducible NO synthase (NOS) and NOS activity as H3-citrulline produced from H3arginine were measured. IL-i and TNF released after 6 hours of lymphomonocytes cultures were also detected. The time course of the NO synthase activity of EC is reported: at the 15th minute values were greater with Cu than PMMA (P < 0.01). EC mRNA for inducible NOS was expressed more after Cu than PMMA HD. IL-i and TNF produced after a 6 hour incubation paralleled the NO profile. In conclusion, the Cu membrane enhanced the production of NO, and the endothelial mediator provided an immediate vasodilatory effect and long-term vasosclerotic potential. Cultured mesangial cells (MC) express cell-matrix adhesion receptors, including the widest and best known family of integrins. They constitute focal contacts between MC and glomerular basement membrane (GBM), fundamental for the regulation of glomerular hemodynamics. We investigated whether integrin expression on cultured human MC could be modulated by native IgA or pre-treated by carbohydrate specific enzymes or IgA/IgG and IgA/lectin aggregates. Human MC displayed strong adhesion to glass coverslips in basal conditions and expressed mostly alpha3-33 and at lower intensity 31 chains of integrins, as judged by immunofluorescence staining. After 12 hours MC produced large amount of fibronectin (F) and laminin (L). Polymeric IgA and even more aggregated IgA and aggregated IgAJIgG strongly decreased MC adhesion, integrin expression, and MC matrix production. On the contrary, Con A and IgA aggregated with Con A increased /31, /33 and alpha3 expression. IgA pretreated with mannosidase and neuraminidase allowed increased adhesion of MC in comparison to untreated IgA, while adhesion was decreased on IgA treated with NAc-galactosidase, fucosidase, NAcglucosaminidase. The expression of /33 chain as well as the production of fibronectin and laminin were variously influenced by the IgA glycosylation.
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Our data suggest that the interactions of native polymeric IgA, IgA with altered glycosylation, aggregated IgA or IgA/IgG or IgA/lectins result in structural rearrangement of glomerular integrins. This phenomenon might lead to modifications in the transmission of MC contraction to the GBM, possibly regulating the glomerular hemodynamics and the production of mesangial matrix. Cattel, Department of Nephrology and Dialysis, Regina Margherita Hospital, Chimica Farmaceutica Applicata Institute, University of Torino, Torino, Italy. Several observations, including an abnormal binding of serum IgA to some lectins and to mesangial matrix glycoproteins, are Consistent with the hypothesis of an altered glycosylation of the IgA molecules in patients with IgA nephropathy (IgAN). To investigate this pathogenetic mechanism, we compared in healthy controls and IgAN patients the profile of IgA eluted from Sepharose columns (4B-CNBr) conjugated with lectins. One lectin from each of the 5 groups classified on the basis of their preferential binding to sugar residues was used (a) concanavalin A, (b) wheat germ agglutinin, (c) soybean, (d) ulex, (e) limulus. Affinity chromatography bound proteins were eluted by the sugars corresponding to the lectins in solid phase: (a) mannose, (b) N-Acetyl-glucosamine, (c) N-acetyl-galactosamine, (d) L-fucose, (e) sialic acid. These were then examined by high pressure liquid chromatography (HPLC; columns: Zorbax GF-250 and Bio-sil SEC-250). Eluted peaks were analyzed by SDS-polyacrylamide gel electrophoresis. By HPLC, sera from IgAN patients showed, in comparison to controls, a highly increased second peak of Con A binding IgA eluted with mannose (300 kD) and a new peak at lower molecular weight (150 kD). The sugar eluted peak was slightly higher in IgAN than in controls in soybean and wheat germ agglutinin and ulex columns. Conversely, the binding capacity of the lectin limulus, specific for sialic acid, was highly decreased in IgAN patients in comparison to controls. These data suggest an altered glycosylation of IgA molecules in sera from patients with IgAN, including a defective expression of sialic acid and an increase in mannose contents.
Hyperfiltration and salt intake in mild to moderate essential hypertension. C. Zoccali, F. Mallamaci, and D. Leonardis, Divisione di Nefrologia e CNR Centro di Fisiologia C/mica, Reggio Cal, Italy. There is now convincing evidence that the GFR is raised in patients with mild to moderate essential hypertension. Because high salt intake causes hyperfiltration and accelerates the progression of renal damage in Dahl rats (a model of salt-sensitive hypertension), we studied the influence of salt intake on the GFR in 14 patients with mild to moderate essential hypertension. Each patient was studied in random order and according to a crossover design, at habitual salt intake, at high salt intake (that is, habitual +50/100 mmol) and at low salt intake (habitual -50/100 mmol). Protein, calcium and potassium intake was fixed across the three study periods. High salt intake caused a significant (P < 0.01) increase in MAP (low salt: 98 1; high salt: 109 2 mm Hg) and the expected suppression in PRA and in plasma aldosterone. Seven patients manifested a MAP increase >10% and were arbitrarily classified as salt-sensitive. The GFR was significantly higher (P < 0.01) at high salt intake (137 12 mI/mm) than at habitual (124 9 mI/mm) and at low salt intake (106 7 mI/mm). In the aggregate urinary salt excretion was directly related with the GFR (r = 0.56, P < 0.001) and the slope of this relationship indicated that a 50 mmol/day increase in salt intake is associated with a 13 mI/mm rise in the GFR. Although GFR changes tended to be more marked in salt-sensitive (+31 mI/mm, range 0-81) than in salt-resistant hypertensives (+ 12 mI/mm, range -7-62) the difference was not significant (P > 0.30) and there was no relationship between changes in GFR and changes in MAP (r = 0.07). The GFR response to salt loading was largely independent (r = 0.1-0.3, NS) of the renin-aldosterone system. At fixed protein intake, changes in salt intake in the physiological range are associated with important GFR changes in mild to moderate essential hypertensives. Because a high GFR in these patients may be a predictor of progressive renal damage, independently of the effect on arterial pressure, high salt intake could be a factor that contributes to nephron obsolescence in patients with essential hypertension.
Diabetes and renal replacement therapy (RRT) in Italy: Analysis of risk factors. C. Catalano, C. Marino, M. Postorino, and P. lacopino. ANED (Ass Naz Emodializzati), Centro di Fisiologia Clinica del CNR e Centro Trapianti Midollo Osseo, Reggio Calabria, Italy. We identified factors which negatively influenced the survival of Italian diabetic patients treated by RRT, by following up those patients who were alive while on treatment on December 31, 1987 (prevalent data), in relationship with a number of putative risk factors. Information concerning diabetes was collected in 1988 while information concerning RRT and mortality data has been gathered annually by the ANED. The first RRT mode of treatment was defined as that which started during the first RRT month which lasted for at least a month. At the end of 1987, 1,573 diabetic patients were treated by dialysis or transplantation: 1286/1573 have been allocated to extracorporeal dialysis (ED), 281 to peritoneal dialysis (PD), while 6 have been directly transplanted. Patients allocated to ED and PD were similar according to age at diagnosis of diabetes (42 vs. 40 years), age at start of RRT (57 vs. 56 years), M/F ratio (1.30 vs. 1.30), proportion of patients with severe sight reduction (39% vs. 37%), and macrovascular complications. Overall survival projected at 60 months was 58%. Risk factor analysis (Cox's proportional hazards regression function) showed that age (RR 1.5, P < 0.001), PD (RR 1.6, P < 0.001) and diabetes duration (RR 1.15, P < 0.01) were associated with a worse survival, while survival was not influenced by sex, region of treatment and type of diabetes. The main result of our study, confirmed both by the univariate and multivariate analysis, is that Italian diabetic patients treated by PD have a lower survival rate compared with those treated by ED. These results should be confirmed by a prospective study. in the maintenance of basal vascular tone in the renal and systemic microcirculation. Controversy exists as to whether NO is also involved in autoregulation of renal blood flow. The split hydronephrotic kidney of the rat was developed as an experimental model for directly observing renal microcirculation in videomicroscopy. In our study we directly measured the in vivo changes of diameters in pre-and postglomerular vessels and glomerular blood flow (GBF) after reduction of renal perfusion pressure (RPP) and blockade of NO synthase. Furthermore, juxtamedullary (JM) arterioles were directly compared in our study with cortical (C) vessels, supplied by the same arcuate arteries. In control animals (N = 4) RPP could be decreased by clamping the aorta above the renal arteries using a micrometer screw from the basal value (mean 112 1.4 mm Hg) to 100, 90, 80 mm Hg. Diameters and GBF were measured 10 minutes after each pressure step. A stepwise pressure-dependent vasodilation was observed in arcuate, C interlobular arteries and C proximal afferent arteriole. C GBF decreased significantly only at a RPP of 80 mm Hg (-13.3 2.1%), while GBF in JM vessels fell significantly even with a RPP of 100 mm Hg (-13.9 3.6%), decreasing progressively as RRP was lowered to 90 mm Hg (-30.1 2.7%) and 80mm Hg (-38.3 3.25%, P < 0.05). Diameters of JM afferent and efferent arterioles tended to decrease with RPP reduction. In the second experimental group (N = 8) NO synthase was blocked by local administration in the tissue bath where the preparation was immersed in 1 x iO at NG-nitro-L-arginine methyl ester (L-NAME). Thirty minutes after L-NAME application, RPP was reduced stepwise from baseline (mean 110 0.9 mm Hg) to 100, 90 and 80mm Hg. Arcuate arteries, C interlobular arteries and C afferent arterioles dilated to a similar degree as in untreated animals. C GBF did not change significantly even when RPP was lowered to 80 mm Hg. Afferent and efferent arterioles of JM glomeruli dilated significantly at reduced RPP (P < 0.05), and in contrast to untreated animals GBF did not fall over the whole pressure range considered in this study. GBF JM was maintained even with a RPP of 80 mm Hg (-13.1 11.9%). In conclusion, pressure-dependent dilation of pre-glomerular vessels and autoregulation of GBF was preserved in C vessels after L-NAME. In JM arterioles, which do not autoregulate in our model, the pressure/flow relationship was improved when NO synthesis was inhibited. Our data suggest that NO release influences vascular responses and pressure/flow relationship in JM vessels, but not autoregulation of C glomeruli. patients. In 18 patients with anti-HCV abs, we measured the levels of serum IgG subclasses (IgG 1, IgG 3, IgG 4) directed to different epitopes of the genomic viral proteins: 3 core peptides (1-28, 21-38, 51-68); 3 of NS5 and 1 of NS4 (non-structural region); 1 of the envelope (structural region). Moreover, typing of HLA genes of class II, DR beta, DO alpha and DO beta (RFLP) was carried out. Abs reacting to one or more viral peptides were found in all patients: 2 patients had abs directed to 1 peptide; 7 patients to 2 peptides; 6 patients to 3 peptides; 2 patients to 4 peptides. Serum samples of all patients were reacting to core peptides: 17 patients (94.4%) had abs against peptide 1-28 (14 IgG 1, 10 IgG 3, 8 IgG 4); 10 patients against 21-38 (10 IgG 1); 9 patients against 51-68 (8 IgG 1, 1 IgG 4). With regard to NSS, 3 patients had abs against peptide 1; 3 patients against peptide 2 (IgG 3); 1 patient (also reacting against peptide 1) had abs against peptide 3. No patients showed abs directed against NS4 and Envelope I antigens. HLA gene frequencies did not differ from those of control population (108 healthy blood donors). Many DR 1 patients recognized the peptide 1 of NS5 (P = 0.019). Our study confirms that HCV infection, in association to female sex, is a predisposing factor to EMC. More studies are needed to ascertain if the different repertoire of immune response to different HCV antigens may play a role on pathogenesis of EMC. Genealogical investigation enabled us to discover different degrees of familial relationships in 20 out of 140 (14%) patients, belonging to 8 family groups. Typing of HLA genes of class II (RFLP) and C4A, C4B, Bf phenotype analysis was carried out in some families. 1st family: (2 parents, 3 sons, 1 daughter): 2 brothers, sharing one HLA haplotype (bearing DR beta 8, DO beta 3a, DQ alpha ib, C4A 3, C4B 1, Bf S) had IgAN. The disease was identified in 2 additional members of the kindred, sharing the same HLA haplotype, with a first-cousin relationship with the father. 2nd family: (2 parents, 2 sons, 1 daughter): 1 son had IgAN; the brother who did not share any HLA haplotype had clinical glomerulonephritis. IgAN was diagnosed in a paternal aunt sharing one HLA haplotype (DR beta 4, DO beta 3a, DO alpha 3, C4A 4, C4B 2, Bf S) and in a young male with a first-cousin relationship. 3rd family: (2 parents, 2 sons, 1 daughter): the father, 1 son and the daughter had IgAN. The affected children did not share any HLA haplotype. 4th family: (2 parents, 2 sons, 1 daughter): 1 son and the daughter, sharing one HLA haplotype bearing DrR beta 1, DO beta la, DO alpha la, C4A 3, C4B 1, Bf S, had IgAN. 5th family: (4 brothers, 3 sisters): 2 brothers, sharing HLA-DR beta 11, had IgAN. 6th family: (2 parents, 1 son, 2 daughters): 1 son and 1 daughter had IgAN. The other daughter had clinical glomerulonephritis. All patients shared DR beta 1. 7th family: (mother, 3 sons): 2 brothers had IgAN. Immunogenetic study was not done. 8th family: (2 parents, 4 sons): the father and one son, sharing HLA-Dr beta 13, had IgAN. Our data confirm a possible genetic influence on pathogenesis of IgAN. More additional familial cases are needed to ascertain the possible relation of IgAN to the HLA system. Prediction of end-dialysis sodium plasma water concentration in PFD through ultrafiltrate conductivity kinetic model. S. Di Filippo, M Corti, S. Andrulli, and F Locatelli, Nephrology and Dialysis Department, Lecco Hospital, Lecco, Italy. Clinical implementation of the sodium kinetic model (NaKM) requires measurement of initial sodium plasma water concentration (Na) at the start of each dialysis session; consequently, NaKM is seldom routinely applied. In PFD, ultrafiltrate conductivity (UFC) can be continuously measured and, through an appropriate kinetic model, dialysate and reinfusate conductivities necessary to obtain a target UFC can be recognized. If UFC and Na are related linearly, the conductivity kinetic model (CKM) may allow indirect routine implementation of NaKM. Fourteen non-diabetic patients were selected for study. The validity of CKM was evaluated by calculating the difference between end-dialysis measured and predicted UFC (UFC M-P). Regression of measured Na (NapwM) on UFC with 95% individual confidence limits was used to test the power of prediction of the individual NaM from UFCM. Mean value, standard deviation, and individual error of UFC M-P were -0.01, 0.05 and 0.10 mS/cm, respectively. The mean UFC M-P of -0.01 is very small, not significantly different from 0 (t = 0.75, P = NS); thus, the prediction value is unbiased. Individual error from predicted value was less than 0.10 mS/cm supporting the validity of the UFC model. Regression of NaM on UFC is shown in the figure: between values of 14 and 15 mS/cm, the 95% confidence limits for the predicted individual value of NaM show that individual error in predicting Na is less than 2 mEq/liter. In conclusion, CKM allows prediction of end-dialysis Na without the need for blood sampling and determinations; the clinical effects of routine indirect NaKM implementation need to be evaluated. Remuzzi, Mario Negri Institute and Ospedali Riuniti, Be,gamo, Italy. Colchicine has been used with beneficial effects in autoimmune diseases. Here we investigated the possibility that coichicine, by virtue of its immunosuppressive properties, could induce a state of tolerance to a highly reactive renal allograft in the rat. Untreated Lewis rats (N = 6), given a major histocompatibility complex incompatible kidney allograft from Brown-Norway (BN) rats, rejected the graft within 12 days. Coichicine at the daily i.p. dose of 40 (N = 6) or 10 (N = 4) jsg/kg promoted long-term survival of kidney graft (>170 days). Decreasing the dose of coichicine to 4 jxg/kg/day (N = 4) failed to prevent graft rejection that occurred within 10 days. Experiments have also been performed to evaluate the effect of colchicine (40 ,ttg/kglday) withdrawal at different time intervals from transplantation (12, 6, 1 months or 15 days) on allograft survival. Graft survival after coichicine discontinuation is as follows: Italy. We reviewed the charts of 164 patients on the waiting list in our transplant center over the last two years. Thirty-one patients were affected by ADPKD, 133 by other nephropathies (ON), and 36 were transplanted in the 2 years which were considered. The prevalence on the waiting list of the ADPKD patients was 18.9%. The mean age of the patients at presentation for the waiting list was 53.12 5.4 years for ADPKD patients versus 43.29 11.23 years for patients with ON. ADPKD patients did receive a mean of 0.9 blood units compared to 1.96 for patients with ON. Mean daily urine output was about 700 dl in the case of ADPKD patients versus 350 dl in patients affected by ON. Mean blood Hb was 10.25 g/dl for ADPKD patients versus 9.05 g/dl for patients with ON. Pretransplant nephrectomy was performed in 11 patients with ADPKD. In 5 patients autologous blood previously collected was utilized in order to avoid sensitization and infections. On the whole, 8 patients with ADPKD and 28 patients with ON have been transplanted. One year actuarial graft survival in ADPKD patients was 100% versus 86% graft survival rate for patients affected by ON. Major clinical problems in the post-transplant period in the case of ADPKD patients have been eiythrocytosis and higher CsA blood levels, mainly in patients affected by cystic liver disease. Prevalence of ADPKD in patients on the waiting list is higher with respect to the prevalence of ADPKD patients with ESRD. ADPKD patients have a higher mean age (P 0.01), higher blood Hb, and higher urine output.
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These facts reflect better clinical conditions. The main surgical correction for ADPKD patients is nephrectomy, which should be performed by autohemotransfusions in order to avoid sensitization. A good graft outcome is higher for patients with ADPKD (P 0.01).
Assessment of coronary risk in asymptomatic elderly candidates for renal transplantation (RT) with dipyridamole Tc-MIBI spect (DMS) and coronary angiography (CA): Results and critical evaluation. G. Squiccimarro, G.P. Segoloni, M Baccega, A. De Berardinis, and A. Vercellone, Divisions of Nephrology, Cardiology, and Nuclear Medicine, S. Giovanni Hospital, Turin, Italy. Asymptomatic coronary artery disease (CAD) is one of the most important risk factors in RT either for early or long-term mortality (50% of cardiovascular early exits for recipients more than 55 years old, in our experience). Since 1992 we routinely perform DMS (cost: $440) as a preoperative screening of asymptomatic non-diabetic patients 55 years old, and CA (cost: $880) for DMS+ patients only. Eighty-two patients were studied: mean age 60 32 years (range 55-69, median 59.4), mean duration of RDT 66.1 61 months (range 4-260, median 45.5). In 64/82 cases DMS did not show myocardial ischemia, and 10/64 patients have been transplanted, with no cardiac mortality in the followup. In 18/82 patients (22%) DMS showed myocardial perfusion defects; 12/18 underwent CA up to now: one had a normal finding, 4 showed "subcritical" CAD (2 transplanted, 2 still on the waiting list), 7/12 showed critical ( 70%) CAD (2 excluded from the waiting list by the cardiologist for trivasal disease, 5 accepted by the cardiologist but excluded by the transplantation team). We believe that this two-step screening may be useful in ruling out among asymptomatic patients those (22% of elderly patients) with CAD consistent with a higher risk of cardiac complications in the post-transplant period. Once the coronaric damage is assessed, however, it seems suitable to accept CAD critical patients on the waiting list (and in some instances also subcritical) taking into account not only the cardiologist's advice, but also a comprehensive clinical evaluation by the transplantation team. Further investigations are needed to decide if the acceptance of patients with subcritical lesions is suitable in terms of cost/benefit balance.
Renal transplantation in microscopic polyarteritis with persistent anti-myeloperoxidase antibodies. G.M. Frascà, L.C. Borgnino, L. Neri, M Martello, E. Sestigiani, and V Bonomini, Institute of Nephrology, University of Bologna, Bologna, Italy. Microscopic polyarteritis (MPA) is frequently associated with necrotizing crescentic GN which may progress towards ESRD, requiring renal replacement treatment with dialysis or transplantation. In most cases anti-neutrophil cytoplasmic autoantibodies specific for myeloperoxidase (MPO-ANCA) can be detected. Their possible persistence in the circulation for a long time raises the problems of the safety of renal transplantation, the possibly increased risk of recurrence, and the most appropriate immunosuppressive regimen. This study reports on 3 patients (1 M, 2 F; age 18-43 years) on regular dialysis for crescentic GN associated with MPA and a persistently high titer of MPO-ANCA without any clinical manifestations of vasculitis. They underwent renal transplantation from a cadaver donor 6-63 months after the onset of the disease. The immunosuppressive protocol included: (a) methyiprednisolone (initial dosage: 15 mg/kg/day, tapered to 0.5 mg/kg/day after 4 weeks, and to 0.3 after 8); (b) cyclosporine (initial dosage: 7 mg/kg/day); (c) azathioprine (initial dosage: 2 mg/kg/day). Graft function recovered in all patients immediately after surgery, and the MPO-ANCA titer progressively decreased. One patient underwent transplantectomy for surgical complications 3 months later, while the serum creatinine was 2.1 mg%; the remainders have a well-functioning graft after 21 and 38 months, respectively, there is no clinical sign of disease recurrence, and MPO-ANCA titer is within the normal range. We conclude that MPA patients can undergo renal transplantation even if ANCA persists at a high titer in the circulation. In this case, immunosuppressive therapy with steroids, cyclosporine and azathioprine seems an appropriate treatment protocol. TPD treatment based on the PET is hypothetically susceptible to errors, due to the difference between the long equilibration times of the PET and the short dwell times currently used during TPD, as well as to the different way equilibration between dialysate and plasma is achieved during TPD compared to other PD modalities. The relationship between PET-derived solute clearances and measured solute clearances should therefore be reassessed for TPD. Eleven patients (mean age 12.4 3.3 years, mean body weight 34.2 15 kg) underwent both a standardized TPD run (initial fill volume 40 mllkg, tidal volume 50%, dwell time 10 minutes, treatment time 8 hours) and PET was performed. DIP ratios for creatinine and urea were calculated at the 5th and 7th TPD exchanges (approximating the equilibration time of the TPD run) at the time points of the PET and on the total TPD dialysate volume. Correlation coefficients between 15, 30 and 60 minute PET-derived DIP ratios and total TPD dialysate-derived DIP ratios were poor. In conclusion, it is possible to predict TPD solute clearances, and consequently the suitability of patients for TPD, based on the DiP ratios for creatinine and urea at the 7th TPD exchange of a standardized TPD run. This index could represent a new test for TPD prescription, more reliable than the standard PET and easier to perform than the direct measurements on the total TPD dialysate volume.
The antiphospholipid antibodies (APA) in SLE: Symptomatic therapy or war to the knife? S. Ferrero, C. Canavese, M. Dogliani, A. Thea, P. Stratta, and A. Vercellone, Department of Nephrology, University of Turin, Turin, Italy. The therapeutic choice in SLE with APA is not defined: it is uncertain if it is enough to employ symptomatic therapies (antiaggregant or anticoagulant) to prevent thrombotic complications or if it is mandatory to use an immunosuppressant in order to delete these antibodies in the hypothesis that APA plays a pathogenetic role. In 34 cases of SLE with APA in the last 10 years, APA were only transiently positive in 16 patients (group A), while persistent in 18 (group B). The most striking clinical and biochemical differences between the two groups were the higher frequency of lupus-like syndrome (5.5% vs. 50%), thrombocytopenia (22% vs. 82%), microangiopathic hemolytic anemia (0% vs. 25%) and association of high titer ELISA detectable APA to functional LLAC demonstration (25% vs. 69%) in group B. Only in this group was thrombosis recurrent, despite prolonged immunosuppressive treatment, antiaggregant therapy, and low dosage anticoagulant schedules. We conclude that APA seems to belong to two different subsets: "rouge" APA are hard to be deleted. Before a clear pathogenetic role is demonstrated, an aggressive immunosuppressive therapy does not seem to be justified.
High dosage oral calcitriol (C) and zero calcium solutions in CAPD patients. R. Scanziani, B. Dozio, F. Malberti, B. Corradi, E. Imbasciati, and M Sudan, Renal Units, Desio and Lodi, Italy. Oral intermittent C is effective in severe hyperparathyroidism (HPTH) of some CAPD patients refractory to continuous administration, but its use is limited because of the occurrence of hypercalcemia. For this reason, in 9 patients with severe HPTH we induced a negative peritoneal balance of calcium (-417 48 mg124 hr) by using zero Ca bags, in order to treat the patients with high dose oral C (4 sg X 3/week) and non-aluminum phosphate binders (CaAc 1.2 0.8 and MgCO 1.9 1.6 g of Ca and Mg elements). After the occurrence of hypercalcemia C was reduced or suspended in 2 patients after 2 or 3 months. The lowest values of PTH were achieved after 15 days in 7/9 patients, when C was in the therapeutic range in all the patients and hypercalcemia (PCa> 11.7 mg/dl) was found in 39% of weekly controls. The decrease in PTH at the end of the study (vs. baseline) was >50% in 2/9 and >20% in 3/9; 4/9 patients were sent to parathyroidectomy for refractory HPTH (the decrease of PTH was <20% vs. baseline). Shown in the table are the serum levels of ionized Ca, P, PTI-I and C during the study and the doses of C administered. ap < 0.05. bp < 0.01. "P < 0.001 vs. baseline.
Conclusions:
(1) Peritoneal Ca loss using zero Ca bags does not determine hypocalcemia and allows the long-term use of large doses of C; (2) the lowest PTH is observed within 15 days; (3) high dose oral C associated with zero Ca solutions can effectively suppress PTH secretion in some CAPD patients, considered refractory with oral continuous treatment.
Pregnancy after kidney transplantation. P. Stratta, on behalf of the Kidney and Pregnancy Group of the Italian Nephrology Society. Pregnancy after kidney transplantation has been successful in more than 1,500 women all over the world. Favorable results have been reported in 60 to 92% of pregnancies, depending on the exclusion of abortions and early complications before the third month. The Kidney and Pregnancy Group of the Italian Nephrology Society studied pregnancy and kidney outcomes in 45 patients with 51 pregnancies (one twin birth). The therapy at the beginning of pregnancy was: steroids (STER) + azathioprine (AZA) (N = 23), STER + cyclosporin A (CsA) (N = 19), STER + AZA + CsA (N 8), AZA + CsA (N = 1); during pregnancy therapy was increased in 4 patients (4 STER), reduced in 3 patients (2 STER + 1 AZA), and stopped in 2 patients (AZA). We observed 34 regular births, 17 premature births (33%), and Cesarean sections in 76% of patients. All newborns were alive at birth; the weight averaged 2.5 0.56 kg. There were 3 perinatal deaths at 6, 7, 27 days after delivery, respectively). We observed: 2 malformations (interventricular communication, bowel athresy), and 2 perinatal complications (3.8%). Blood creatinine and proteinuria changed respectively from 1.12 0.30 mgldl and 40 72 mg124 hr before pregnancy to 1.22 0.6 and 155 89 one month after delivery, to 1.4
and 654 2290
(2 patients 1 g/24 hr) 12 months after delivery. Maternal complications were: 1 interstitial acute rejection (1.9%) at 1 month after delivery, 3 preeclamptic episodes (5.8%), 4 urinary tract infections (7.9%), and 1 colestatic jaundice. Blood pressure remained unvaried before and after pregnancy (in 3 patients only was a hypotensive therapy added). Our experience confirms good results obtained in pregnancy after kidney transplantation; careful choice of patients is needed, according to Davison's criteria. Maternal and fetal risks could be reduced by careful interdisciplinary check-up.
Effects of nitrendipine (NT) on urinary enzyme and protein excretion after non-ionic radiocontrast (RC) administration. M Carraro, W. Mancmi, M. Artero, F. Stacul, M Grotto, and L. Faccini, Institutes of Patologia Medica and Radiologia, University of Trieste, Trieste, Italy. The effects of single doses of a calcium antagonist on urinary enzyme and microprotein excretion after non-ionic RC administration were studied in a controlled, randomized, double blind protocol consisting of 121 patients (mean age 65.3 9.3 years; 62% male) with normal renal function who were to undergo digital subtraction angiography (DSA). The.patients were treated with placebo or NT 10 mg or 20 mg p.o. 1 hour before DSA. Blood and urine samples were collected 1 hour before and after and 24 hours after DSA. Study variables included: contrast volume, serum creatinine, Na, K, and osmolality; urinary creatinine, osmolality, albumin, alanylaminopeptidase (AAP), N-acetyl-/3-glucosaminidase (NAG), and n-1-microglobulin (a1m). AAP, NAG, and a1m increased following RC administration, all except AAP returning to baseline after 24 hours. Pretreatment with NT had no protective effect on enzyme excretion, although AAP levels were lowered in general with the 20 mg dose. The incidence of acute renal failure 24 hours after DSA was equal in the three groups. This study indicates that a single low or normal dose of NT p.o. is not an effective prophylaxis before RC administration, perhaps due to hepatic first-pass kinetics.
Intraindividual variability of cyclosporine blood trough levels on patients' immunosuppression. A. E114 P. Palazzi, F. Nicosia, S. Zafiropulu, and F. Quarto di Palo, Clinica Medica 1, Transplant Unit, Università di Milano, Milano, Italy. In this study we evaluated the practical importance of CSA trough blood levels intraindividual variability in a group of 100 non-immunized cadaver renal transplants. During a five year period we calculated in each patient blood mean CsA level and its variation coefficient (CVC). The mean intraindividual variability of CsA blood levels was 25.3% (mm 5, max 71%, the median 27.7%). Patients were divided into two groups: Group A with a CVC < 28%, group B with a CVC > 28%, and they were compared for graft function and survival.
Patients of group A showed a great stability in renal function and in the 5 year observation period only 10.5% of the kidneys were lost for rejection. In patients of Group B plasma creatinine levels increased in time from 122 3.8 to 179 11.5 zmIliter at the 5th year (P < 0.001). Creatinine clearance decreased (P < 0.05) and a greater number of graft losses (31.9%) was also observed. After the 1st year of observation the survival curves and the data of the two groups were statistically different. In conclusion, an elevated intraindividual variability of CsA trough blood levels is associated with an increased risk of renal function deterioration and graft loss.
Short-term immunosuppression with CTLA4Ig, a soluble form of the T cell activation molecule CD28: Prolonged renal allograft survival in rats.
G. Remuzzi, 0. Imberti, M. Bontempelli, and N Perico, Mario Negri Institute and Ospedali Riuniti, Bergamo, Italy. Allograft rejection is a process that depends on T cell receptor-ligand interaction and costimulatory signals generated when accessory molecules bind to their ligands, such as CD28 to the B7 molecule. We investigated the possibility that B7 blockade in vivo by the soluble CD28 receptor homolog CTLA4Ig modulates the rejection process in a rat model of kidney allograft. Lewis rats orthotopically transplanted with MHC incompatible kidney from Brown-Norway (BN) rats were given an i.p. injection of CTLA4Ig (0.2 or 0.5 mg/day) or a non-specific immunoglobulin (Ig 0.5 mg/day) for 7 days, starting the day of transplant. Graft survival is as follows:
Graft survival days
Median CTLA4Ig 0.2 mg/day 36, 40, 43, 45, 47, 50 44 CTLA4Ig 0.5 mg/day 40, 48, 50, 55, 60 50 Ig 0.5 mg/day 8, 8, 9, 10, 10 9
In all CTLA4Ig-treated rats renal grafts were well functioning 30 days after transplantation as documented by serum creatinine concentrations, comparable to age-and sex-matched control rats (0.65 0.08 mg/dl). At this time in vitro mixed lymphocyte culture experiments showed a significant reduction of proliferation of peripheral blood lymphocytes from CTLA4Ig-treated rats when challenged with BN, but not third party Wistar Furth lymphocytes. These findings indicate that: (1) the interaction between CD28 and B7 is an essential costimulatory signal in the process of allograft rejection;
(2) a short-course of CTLA4Ig prolonged renal allograft survival in the rat.
Immunohistochemical distribution of adhesion molecules on biopsies of well-functioning renal transplantS. L. Murer, G. Basso, G. Montini, R. Dall'Amico, B. Andreetta, A. Scarpa, E. CurrO-Dossi, and G. Zacchello, Department of Pediatrics, University of Padova, Padova, Italy. Adhesion molecules regulate cell-cell and cell-matrix interaction during the immune response to alloantigens. Up-regulation of ICAM-1 and HLA-DR on renal tubular cells has been observed during renal allograft rejection, and endothelin (ET) has been proposed as a proinflammatory agent during cell-mediated events that include macrophage infiltrate. We have studied the immunohistochemical distribution of HLA-DR, ICAM-1, VCAM-1, of leukocyte ligands LFA-1 and VLA-4, and of ET on 18 graft biopsies obtained from well-functioning renal transplants (serum creatinine x 75.1 jsmol/liter). Interstitial infiltrate was also evaluated. As controls, normal renal tissues obtained from 4 nephrectomies, were analyzed for renal carcinoma. In the controls, there was no evidence of inflammation; the tubules were HLA-DR and adhesion molecule negative, and ICAM-1 and VCAM-1 were expressed only by glomerular and interstitial capillaries and by Bowman's epithelial cells, respectively. ET staining was absent or weak only on vascular endothelium. Inflammatory infiltrate was observed in 12/18 renal graft biopsies (4 severe, 3 moderate, 5 weak); in all of the biopsies, 90% of infiltranting cells were LFA-1 positive and a severe positivity (+cells > 50/area) was present in 9/18 cases. ing cells have been reported to increase extracellular matrix (EM) deposition and to modulate the expression of EM receptors. In the present study, the expression of j31(a1-a6) and a133 integrin receptors and ICAM-1 and VCAM-1 counter-receptors (CR) was evaluated on renal biopsies of 5 patients affected by CGN using an immunohistochemical technique. Indirect immunofluorescence showed C3 and IgG immune deposits (ID) in 2 cases, while no ID were found in the 3 patients with anti-cytoplasmic antibodies. The expression and distribution pattern of integrins, ICAM-1 and VCAM-1 were similar in both types of CGN. On collapsed flocculi, the expression of a1, a2, a3, a5, a6, a subunits and ICAM-1 was regularly very low. On each cell of recently developed crescents, a3, a, ICAM-1 and VCAM-1 were strongly expressed, while a4 and a5 stained clusters of infiltrating leukocytes. Only trace amounts of all the adhesion molecules examined were detected in fibrous crescents. In the periglomerular areas presenting a heavy infiltrate, ICAM-1 was detected on the brush border of 40-80% of tubuli, and a basolateral expression of a2, a3, a5, a,, subunits and VCAM-1 was found on 70-100% of the tubuli. The expression of different adhesion molecules on cellular crescents and the marked up-regulation of the same molecules on tubuli may be due to the increased production of cytokines, in particular TGF-13, in this highly aggressive GN.
New markers in the evaluation of persistent hyperparathyroidism after kidney transplantation. F. Vaccaro, A. Pagano, MC. Gioviale, S. Cavera, F.P. Picone, and M Romano, Chair of Surgical Pathology "R", Department of Hemodialysis, Nephrology and Organ Transplantation, University of Palermo, Palermo, Italy. Although kidney transplantation removes the metabolic stimuli leading to secondary hyperparathyroidism (HPT), the excessive excretion of parathyroid hormone (PTH) may persist or return after the transplant. Several authors report cases of latent HPT in kidney transplant patients with normal calceniia, which in time may lead to loss of bone mass. At the present time, the most widespread biochemical markers of bone reabsorption are urinary pyridinoline (Pyd) and deoxypyridinoline (Dpd). The aim of our study was to evaluate the bone turnover of kidney transplanted patients with normal calcemia and iPTH levels at the upper normal limits. We determined the urinary concentration of the collagen cross links (Pyd and Dpd) (Elisa, Metra Biosystems, USA) in 20 patients who had successfully undergone kidney transplants (13 men and 7 women, mean age 43.7 8.2 years, mean transplant age 30.4 12.1 months, creatinemia 168.8 13.3 nmol/liter). We also determined serum parameters such as calcemia, phosphoremia, alkaline phosphatase (ALP), iPTH, bone osteocalcin (BGP), and urinary levels of calcium and phosphorous.
All the patients in the group had suspended any drug treatment which might interfere with bone metabolism at least 1 month previously. The table shows the date obtained, with high levels of urinary cross links compared to normal calcemia, phosphoremia and BGP levels, which might suggest a linear correlation with the high levels of iPTH (r = 0.37; P < 0.05). In conclusion, our data indicate that urinary evaluation of cross links might reveal any increase in bone reabsorption due to persistent HPT, even when other more common markers prove to be within normal limits. Normal renal tissue is able to synthesize several complement components, including C3 and C4. The pathogenic role of complement has been well characterized in hyperacute (antibody-mediated) rejection, but little is known about the role of complement in acute cellular rejection. We therefore investigated the role of intrinsic renal production of C3 in acute renal allograft rejection, and whether local C3 production is correlated with histological and clinical outcomes. Thirty biopsies of renal transplant cortex were compared to cortical tissue from 7 normal kidneys. Cortex was processed immediately, and all biopsies were performed for standard clinical indications. Total RNA was extracted using a microadaptation of single step phenolchloroform technique, and first strand eDNA synthesis performed from mRNA using oligo(dt) 12-18. C3 eDNA fragments were then co-amplified in the same tube in the presence of [32p] dCTP and PCR primers specific for a control (housekeeping) gene, glucose-phosphate-isomerase (UPI). Results were expressed as the ratio of the intensity of the C3 product to that of the GPI band on autoradiography. The presence of mRNA transcript for C3 was confirmed in all normal tissue and transplant biopsies. Overall, 24/30 transplant biopsies exhibited a higher C3 expression than the maximum control tissue (mean 0.40 0.10 SEM biopsies vs. 0.038 0.009 controls, P < 0.005). In those patients with clinical and histological evidence of pure cellular rejection, however, 13/14 biopsies had an increased C3 expression (mean 0.51 0.085, P < 0.005). In contrast, 4/5 biopsies showing pure cyclosporine toxicity had normal C3 expression. There was a significant correlation between C3 mRNA expression and the amount of C3 deposited in the tubular basement membrane (r = 0.43, P < 0.005). In contrast, there was no correlation between C3 expression and mononuclear cell infiltration. We concluded that local renal C3 synthesis is increased in acute allograft rejection but is poorly correlated with cellular infiltration. Local C3 synthesis may play a role in acute rejection and should be explored further.
Ca
Peritoneal dialysis prescription: The "clearance peak" model. G. Vi,a, G. Amici, G. Da Rin, A. da Porto, and C. Bocci, Nephrology Division and Laboratory, Treviso Hospital, Treviso, Italy. Peritoneal dialysis prescription involves setting up a personalized dialysis schedule aimed at obtaining satisfactory clearance and ultrafiltration rates while respecting the patient's lifestyle as far as possible. By calculating the creatinine clearance (Ccr) from 2 exchanges with dwell times (DT) of 4 and 8 hours, respectively (2 liters, 2.27%) in 21 uremic patients (age 62.7 10.5 years, on CAPD for 23 18 months), curves (y = ah2 + bh + c) were plotted with 3 points (0, 4, 8 hr) for Cr (y) and volume (Vol, y) as a function of the DT (h). The DT corresponding to the Ce,. peak (CIPeak-t, range: 4 hr 35 mm-il hr 10 mm) was calculated for each subject with the 1st derivative (h = -b/2a) of the function. On the basis of the Cr that can be obtained with the 3 most common DT (4, 6, 8 hr), we divided the patients into 3 categories (CI peak-t < 5 hr: "fast"; 5-7 hr: "normal"; >7 hr: "slow") for the best C. correspondence of the 4, 6 or 8 hour exchanges, respectively. Also, the Cr (y) and Vol (y) 8 hr/4 hr ratios were related to CI Peak-t (h) (y = ah2 + bh + c, r2 = 0.983 and 0.781, P < 0.001). DAPD (4 hr x 4) DAPD (4 hr X 4) CAPD (8 hr x a (6 hr X 4): ¾ bags-1.36% for normal, ¼-1.36% for slow b (8 hr X 3): bag volume from +25% (CIPeak-t = 7 hr) to +10% ( 9 hr)
Fast
The "CIPeak" model identifies the most advantageous DT for each patient by using the C. values of two 2.27% exchanges of 4 and 8 hours, respectively. Functional classification into 3 categories may give a rational orientation to dialysis prescription.
Can asymptomatic women carriers of the Alport syndrome gene be accepted as living kidney donors? A. Pietrucc4 M. Meroni, S. Carozzi, S. Tazzari, L. Tom Tarelli, F. Giordano, A. Renieri, M. De Marchi, U Valente, and A. Sessa, Units of Nefrologia e Dialisi, Savona e Vimercate; Anatomia Umana Normale, Milano; Anatomia Patologica, Vimercate; Genetica Medica, Siena; Chirurgia Trapianti, Genova, Italy. Female carriers of the Alport syndrome (AS) gene should avoid living kidney donation even though oligosymptomatic, because of the risk of progression of the glomerular lesions in the remnant nephrons; for the same reason, the survival of the grafted kidney may be limited. We observed two transplanted brothers affected with AS, receiving the kidneys from the father (Tpl) and the mother (Tp2), respectively. Molecular analysis showed linkage with COL4A5 gene on the X chromosome, but so far direct search did not succeed in revealing the gene defect on the examined exons. Two years after transplantation, Tpl was well-functioning; Tp2 had a mild deterioration in GFR for a recent episode of rejection and a subsequent CMV infection. The mother presented microscopic hematuria and normal GFR. A graft biopsy was performed in Tp2 because of persistent microscopic hematuria and glomerular proteinuria: LM showed non-specific glomerular alterations, tubulointerstitial infiltrates and segmental arteriolar thickening. IF was negative, and EM showed an appearance of the glomerular basement membrane consistent with AS. Renal transplantation in AS raises some questions: (1) the low prevalence of anti-GBM nephritis does not contraindicate transplantation in AS and also from a living healthy father; (2) the living donation is not advisable in females with relevant lesions of the GBM, proteinuria, deafness and/or typical ocular abnormalities; (3) female carriers of the AS with isolated microscopic hematuria may be evaluated as living kidney donors, as long as a long-term follow-up will not provide evidence for an increased risk of progression to ESRD in the remaining kidney.
